Paradigm Health has raised $78 million as it works to revamp the clinical research ecosystem, while also announcing a deal to ...

GE HealthCare and the Mayo Clinic are expanding their long-running collaborative work to now include the development of new personalized radiation therapy approaches for cancer, with a pl | The ...

The FDA has placed a hold on Denali Therapeutics’ plans to launch a phase 1 rare disease trial, citing concerns about immune ...

In 2003, Medtronic first received a humanitarian green light from the FDA to offer its deep brain stimulation implants to ...

In return, Royalty will receive a 9.25% royalty on worldwide sales of tividenofusp alfa from Denali until it reaches three times the amount Royalty has handed to Denali—or, alternatively, 2.5 times ...

Lagging behind the PD-1xVEGF leaders, Crescent has strengthened its hand by licensing Kelun’s integrin beta-6 ...

Almost four years after penning its first amyloidosis collaboration with Neurimmune, AstraZeneca has returned to ...